Kyowa Kirin Deal Strengthens Road Ahead For Kura’s Menin Contender

Beaten To Market But 1L Opportunity Beckons

 
• By Ian Haydock
  
Acute myeloid leukemia a 3d-Render
AML with mutations the initial target of Kura/Kyowa Kirin deal • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Deals

More from Scrip